A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2013
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 20 Aug 2010 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
- 20 Sep 2007 The expected completion date for this trial is now 1 Nov 2006.
- 30 Aug 2007 Status changed from in progress to completed.